Ataxin 2 anticorps (Middle Region)
Aperçu rapide pour Ataxin 2 anticorps (Middle Region) (ABIN927703)
Antigène
Voir toutes Ataxin 2 (ATXN2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Réactivité croisée
- Souris, Boeuf (Vache), Chien
-
Purification
- Purified
-
Immunogène
- ATXN2 antibody was raised in rabbit using the middle region of ATXN2 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
ATXN2 Blocking Peptide, (ABIN939080), is also available for use as a blocking control in assays to test for specificity of this ATXN2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- Ataxin 2 (ATXN2)
-
Autre désignation
- ATXN2
-
Sujet
- The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA ty. Synonyms: Polyclonal ATXN2 antibody, Anti-ATXN2 antibody, ataxin 2 antibody, ATX2 antibody, FLJ46772 antibody, SCA2 antibody, TNRC13 antibody.
-
Pathways
- Ribonucleoprotein Complex Subunit Organization
Antigène
-